Background. Chlorhexidine (CHG) body washes prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission and nosocomial blood stream infections among intensive care unit (ICU) patients. CHG tolerance can be conferred by qac A/ Bresistance genes. The long-term use of CHG bathing may result in the emergence of chlorhexidine-tolerant MRSA strains. The objective was to determine the frequency of qac A/B and high-level mupirocin (MUP) resistance among MRSA isolates recovered from active surveillance cultures from the anterior nares. We compared frequencies before and after the introduction of a CHG daily body wash intervention in a surgical intensive care unit.
Methods. Analysis included a random sample of banked MRSA isolates recovered before (2005) and after (2008) (2009) (2010) 2012 ) institution of a CHG bathing protocol. PCR was used to detect the presence of qacA/B. Disk diffusion with a 200 ug mupirocin disk (Oxoid) was used to detect high level MUP resistance; PCR for detection of mupA was performed on all resistant isolates. SCCmec typing was performed using a multiplex PCR assay for SCCmec types I-V. Power analysis assumed a baseline qacA/B prevalence of 1%; to detect an increase in prevalence of 1% per year with a statistical power of 80% 63 samples per year were required.
Results. Sixty-three MRSA isolates per year (out of approximately 250 banked isolates per year), were randomly selected. Of the 315 selected isolates, 30 (9.5%) were qac A/B positive and 26 (8.2%) were MUP resistant. There was no significant difference in the prevalence of qac A/B positive MRSA isolates before (2005: Conclusion. Implementation of a daily CHG bathing protocol among surgical ICU patients did not significantly increase the frequency of qac A/B genes in MRSA isolates recovered from the anterior nares over a 6 year period. The frequency of high level MUP resistance in these strains also remained stable. 
